Structure-Based Design and Synthesis of Apramycin–Paromomycin Analogues: Importance of the Configuration at the 6′-Position and Differences between the 6′-Amino and Hydroxy Series

The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]­octane system. The effect of this modificat...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Chemical Society Vol. 139; no. 41; pp. 14611 - 14619
Main Authors Mandhapati, Appi Reddy, Yang, Guanyu, Kato, Takayuki, Shcherbakov, Dimitri, Hobbie, Sven N, Vasella, Andrea, Böttger, Erik C, Crich, David
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 18.10.2017
Amer Chemical Soc
Subjects
Online AccessGet full text
ISSN0002-7863
1520-5126
1520-5126
DOI10.1021/jacs.7b07754

Cover

Abstract The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]­octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche–gauche or the gauche–trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside–ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.
AbstractList The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically-derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent, yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported, for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomcyin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.
The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.
The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]­octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche–gauche or the gauche–trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside–ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.
The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical binding interactions with the ribosomal target, is replaced by an apramycin-like dioxabicyclo[4.4.0]octane system. The effect of this modification is to lock the hydroxymethyl side chain of the neomycin or paromomycin ring I, as part of the dioxabicyclooctane ring, into either the gauche-gauche or the gauche-trans conformation (respectively, axial or equatorial to the bicyclic system). The antiribosomal activity of these compounds is investigated with cell-free translation assays using both bacterial ribosomes and recombinant hybrid ribosomes carrying eukaryotic decoding A site cassettes. Compounds substituted with an equatorial hydroxyl or amino group in the newly formed ring are considerably more active than their axial diastereomers, lending strong support to crystallographically derived models of aminoglycoside-ribosome interactions. One such bicyclic compound carrying an equatorial hydroxyl group has activity equal to that of the parent yet displays better ribosomal selectivity, predictive of an enhanced therapeutic index. A paromomycin analog lacking the hydroxymethyl ring I side chain is considerably less active than the parent. Antibacterial activity against model Gram negative and Gram positive bacteria is reported for selected compounds, as is activity against ESKAPE pathogens and recombinant bacteria carrying specific resistance determinants. Analogues with a bicyclic ring I carrying equatorial amino or hydroxyl groups mimicking the bound side chains of neomycin and paromomycin, respectively, show excellent activity and, by virtue of their novel structure, retain this activity in strains that are insensitive to the parent compounds.
Author Böttger, Erik C
Mandhapati, Appi Reddy
Vasella, Andrea
Shcherbakov, Dimitri
Kato, Takayuki
Hobbie, Sven N
Crich, David
Yang, Guanyu
AuthorAffiliation Department of Chemistry
ETH Zurich
Institute of Medical Microbiology
Organic Chemistry Laboratory
University of Zurich
AuthorAffiliation_xml – name: Department of Chemistry
– name: Institute of Medical Microbiology
– name: University of Zurich
– name: Organic Chemistry Laboratory
– name: ETH Zurich
– name: a Department of Chemistry, Wayne State University, Detroit, MI 48202, USA
– name: b Institute of Medical Microbiology, University of Zurich, 8006 Zurich, Switzerland
– name: c Organic Chemistry Laboratory, ETH Zurich, 8093 Zurich, Switzerland
Author_xml – sequence: 1
  givenname: Appi Reddy
  surname: Mandhapati
  fullname: Mandhapati, Appi Reddy
  organization: Department of Chemistry
– sequence: 2
  givenname: Guanyu
  surname: Yang
  fullname: Yang, Guanyu
  organization: Department of Chemistry
– sequence: 3
  givenname: Takayuki
  surname: Kato
  fullname: Kato, Takayuki
  organization: Department of Chemistry
– sequence: 4
  givenname: Dimitri
  surname: Shcherbakov
  fullname: Shcherbakov, Dimitri
  organization: University of Zurich
– sequence: 5
  givenname: Sven N
  surname: Hobbie
  fullname: Hobbie, Sven N
  organization: University of Zurich
– sequence: 6
  givenname: Andrea
  surname: Vasella
  fullname: Vasella, Andrea
  email: vasella@org.chem.ethz.ch
  organization: ETH Zurich
– sequence: 7
  givenname: Erik C
  surname: Böttger
  fullname: Böttger, Erik C
  email: boettger@imm.uzh.ch
  organization: University of Zurich
– sequence: 8
  givenname: David
  orcidid: 0000-0003-2400-0083
  surname: Crich
  fullname: Crich, David
  email: dcrich@chem.wayne.edu
  organization: Department of Chemistry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28892368$$D View this record in MEDLINE/PubMed
BookMark eNqNks9u1DAQxiNURLeFG2eUIxKk2E6cOByQli3QSpWotHC2HGe89Sqxt7ZD2VvfgTfhxuv0SXB2t-WPQHCyZ-b3ja2Z7yDZM9ZAkjzG6Agjgl8shfRHVYOqihb3kgmmBGUUk3IvmSCESFaxMt9PDrxfxrAgDD9I9gljNclLNkm-zYMbZBgcZK-FhzY9Bq8XJhWmTedrEy5i6FOr0unKiX4ttbm5_nIunO3tJkqnRnR2MYB_mZ72K-uCMBJGQZSmM2uUXgxOBG1jz7BJljfXX7Nz6_U2GR861kqBgyj0aQPhCsD8IKe9NnaDnaxbZz-v0zk4Df5hcl-JzsOj3XmYfHz75sPsJDt7_-50Nj3LRIFJyJgqqpIoaBpgslSYQKUYwZQxXOG2JUULkjKqCC1q1aqaQi3qukFtA0VRtzg_TF5t-66GpodWgglOdHzldC_cmluh-a8Voy_4wn7itCwqQuvY4OmugbOXcVCB99pL6DphwA6eE4zLGpGSkn-iuM4ZZixHVUSf_Pytu__crjYCz7bAFTRWeanH-d5hoxdwTlGejzcUafb_9EyHzUZndjAhSslWKp313oHicleP49Adx4iPRuWjUfnOqFH0_DfR7Vt_wXeDGZNLO7joOv9n9Dvs4vyD
CitedBy_id crossref_primary_10_1021_acs_joc_0c00910
crossref_primary_10_1021_acs_joc_7b02891
crossref_primary_10_1021_acs_orglett_9b04279
crossref_primary_10_1093_jac_dky546
crossref_primary_10_1002_chem_202400017
crossref_primary_10_1021_acs_chemrev_0c01214
crossref_primary_10_1021_acsinfecdis_3c00233
crossref_primary_10_1039_C8GC00814K
crossref_primary_10_3390_antibiotics12010025
crossref_primary_10_1016_j_jgar_2020_12_006
crossref_primary_10_1002_cmdc_202200486
crossref_primary_10_1021_jacs_0c11106
crossref_primary_10_1016_j_bmc_2019_115121
crossref_primary_10_1021_acsinfecdis_8b00052
crossref_primary_10_1039_D0SC04595K
crossref_primary_10_1021_acs_joc_0c00743
crossref_primary_10_1021_acsomega_3c09226
crossref_primary_10_1021_jacs_4c01233
crossref_primary_10_1021_acs_joc_9b01075
crossref_primary_10_1021_acs_joc_0c01836
crossref_primary_10_3390_molecules23020284
crossref_primary_10_1016_j_carres_2020_107984
crossref_primary_10_1021_acs_orglett_5c00168
crossref_primary_10_1016_j_carres_2021_108254
crossref_primary_10_1021_acsinfecdis_2c00557
crossref_primary_10_1073_pnas_2013315118
crossref_primary_10_1021_jacs_9b01693
crossref_primary_10_1021_acsmedchemlett_1c00349
crossref_primary_10_1039_D1MD00214G
crossref_primary_10_1016_j_tet_2022_133112
Cites_doi 10.1002/cbic.200900779
10.1021/ja0543144
10.1016/j.drup.2012.05.001
10.1128/AAC.00572-10
10.1016/S0040-4039(97)10599-8
10.1039/C5MD00429B
10.1073/pnas.0707265105
10.1021/jm700967e
10.1021/acs.jmedchem.6b00793
10.1002/cmdc.201402146
10.1523/JNEUROSCI.3430-12.2013
10.1038/ng0793-289
10.1073/pnas.1204073109
10.1128/AAC.03239-14
10.1007/978-3-7091-0215-2_20
10.1021/jo971046m
10.1172/JCI77424
10.1039/C5MD00384A
10.1021/ja00234a047
10.1021/ja050918w
10.1056/NEJMc0806397
10.1093/nar/gkm658
10.1039/C39860001570
10.1201/9780585407500.ch11
10.1021/jo00388a038
10.1586/eri.12.25
10.1016/j.bmc.2008.08.053
10.1021/acsinfecdis.5b00069
10.1021/jacs.5b02248
10.1039/C5MD00344J
10.1039/C4SC01626B
10.1002/hlca.200890167
10.7164/antibiotics.27.677
10.1128/AAC.47.8.2565-2571.2003
10.1039/c39830000939
10.1016/0022-2836(87)90349-4
10.1038/35030019
10.1016/S0040-4039(00)99857-5
10.1002/anie.201310843
10.1039/C39880001461
10.1016/S0022-2836(02)01452-3
10.1002/9780470149676.ch9
10.1038/nsmb.2994
10.1007/978-1-4614-1400-1_7
10.1186/1472-6815-7-5
10.1086/420742
10.1021/cb3005116
10.1002/cbic.200300657
10.1021/ja505964r
10.1039/C39870001462
10.1016/j.carres.2017.05.015
10.1073/pnas.0811258106
10.1093/nar/gki862
10.1155/2011/937861
10.1038/ncomms4112
10.1128/mBio.01827-14
10.1126/science.1176667
10.1128/AAC.43.5.1003
10.1086/518605
10.1002/hlca.200590240
10.1039/C4MD00119B
10.1080/07328309408011662
10.1021/jo00170a070
10.1056/NEJMc0806396
10.1093/jac/dkq408
10.1111/j.1445-5994.2011.02452.x
10.3987/S(N)-1978-01-0197
10.1016/j.heares.2013.01.006
10.1021/jo00874a003
10.1586/ERI.12.25
10.1039/c5md00429b
10.1039/c4sc01626b
10.1039/c5md00384a
10.1039/c4md00119b
10.1039/c5md00344j
ContentType Journal Article
Copyright Copyright © 2017 American Chemical Society
Copyright_xml – notice: Copyright © 2017 American Chemical Society
DBID AAYXX
CITATION
17B
1KM
BLEPL
DTL
EGQ
GYRTJ
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1021/jacs.7b07754
DatabaseName CrossRef
Web of Knowledge
Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science Primary (SCIE, SSCI & AHCI)
Web of Science - Science Citation Index Expanded - 2017
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
Web of Science
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1520-5126
EndPage 14619
ExternalDocumentID PMC5647259
28892368
000413503300040
10_1021_jacs_7b07754
b039127859
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: University of Zurich
– fundername: Wayne State University
– fundername: NSF; National Science Foundation (NSF)
  grantid: MRI-084043
– fundername: NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
  grantid: AI123352
– fundername: NIAID NIH HHS
  grantid: R01 AI123352
GroupedDBID -
.K2
02
53G
55A
5GY
5RE
5VS
7~N
85S
AABXI
ABFLS
ABMVS
ABPPZ
ABPTK
ABUCX
ABUFD
ACGFS
ACJ
ACNCT
ACS
AEESW
AENEX
AETEA
AFEFF
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
BKOMP
CS3
DU5
DZ
EBS
ED
ED~
EJD
ET
F5P
GNL
IH9
JG
JG~
K2
LG6
P2P
ROL
RXW
TAE
TN5
UHB
UI2
UKR
UPT
VF5
VG9
VQA
W1F
WH7
X
XFK
YZZ
ZHY
---
-DZ
-ET
-~X
.DC
4.4
AAHBH
AAYWT
AAYXX
ABBLG
ABJNI
ABLBI
ABQRX
ACBEA
ACGFO
ADHLV
AGXLV
AHDLI
AHGAQ
CITATION
CUPRZ
GGK
IH2
XSW
YQT
ZCA
~02
17B
1KM
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
GROUPED_WOS_WEB_OF_SCIENCE
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-a412t-8f4762febbe8c6f12e7f821588171dd24dec585f2549fdf95e9a99b0dbe449d13
IEDL.DBID ACS
ISICitedReferencesCount 32
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000413503300040
ISSN 0002-7863
1520-5126
IngestDate Tue Sep 30 16:45:37 EDT 2025
Tue Aug 05 10:44:31 EDT 2025
Fri Sep 05 05:13:53 EDT 2025
Mon Jul 21 06:05:43 EDT 2025
Mon Sep 01 07:45:18 EDT 2025
Fri Sep 26 20:26:57 EDT 2025
Wed Oct 01 04:01:38 EDT 2025
Thu Apr 24 22:50:51 EDT 2025
Thu Aug 27 13:42:08 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 41
Keywords RIBOSOMAL-RNA METHYLATION
ANTIBACTERIAL ACTIVITY
DRUG DISCOVERY
A-SITE
CRYSTAL-STRUCTURES
BACTERIAL-RESISTANCE
ACUTE TOXICITY
MITOCHONDRIAL 1555A-GREATER-THAN-G MUTATION
AMINOGLYCOSIDE ANTIBIOTICS
CARBOXYLIC-ACIDS
Language English
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-a412t-8f4762febbe8c6f12e7f821588171dd24dec585f2549fdf95e9a99b0dbe449d13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2400-0083
0000-0002-9205-0384
PMID 28892368
PQID 1938188307
PQPubID 23479
PageCount 9
ParticipantIDs crossref_primary_10_1021_jacs_7b07754
acs_journals_10_1021_jacs_7b07754
proquest_miscellaneous_2116902652
pubmed_primary_28892368
webofscience_primary_000413503300040
proquest_miscellaneous_1938188307
crossref_citationtrail_10_1021_jacs_7b07754
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5647259
webofscience_primary_000413503300040CitationCount
ProviderPackageCode JG~
55A
AABXI
GNL
VF5
7~N
ACJ
VG9
W1F
ACS
AEESW
AFEFF
.K2
ABMVS
ABUCX
IH9
BAANH
AQSVZ
ED~
UI2
CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-18
PublicationDateYYYYMMDD 2017-10-18
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-18
  day: 18
PublicationDecade 2010
PublicationPlace WASHINGTON
PublicationPlace_xml – name: WASHINGTON
– name: United States
PublicationTitle Journal of the American Chemical Society
PublicationTitleAbbrev J AM CHEM SOC
PublicationTitleAlternate J. Am. Chem. Soc
PublicationYear 2017
Publisher American Chemical Society
Amer Chemical Soc
Publisher_xml – name: American Chemical Society
– name: Amer Chemical Soc
References ref9/cit9
ref45/cit45
ref3/cit3
ref27/cit27
ref63/cit63
ref56/cit56
ref16/cit16
ref52/cit52
ref23/cit23
ref8/cit8
ref31/cit31
ref59/cit59
ref2/cit2
ref77/cit77
ref34/cit34
ref71/cit71
ref37/cit37
ref20/cit20
ref48/cit48
ref60/cit60
ref74/cit74
ref17/cit17
ref10/cit10
ref35/cit35
ref53/cit53
ref19/cit19
ref42/cit42
ref46/cit46
ref49/cit49
ref13/cit13
ref61/cit61
ref75/cit75
ref24/cit24
ref38/cit38
Mingeot-Leclercq M.-P. (ref21/cit21) 1999; 43
ref50/cit50
ref64/cit64
ref54/cit54
ref6/cit6
ref36/cit36
ref18/cit18
ref65/cit65
ref11/cit11
ref25/cit25
ref29/cit29
ref72/cit72
ref76/cit76
ref32/cit32
ref39/cit39
ref14/cit14
ref57/cit57
ref5/cit5
ref51/cit51
ref43/cit43
ref28/cit28
ref68/cit68
ref26/cit26
ref55/cit55
ref73/cit73
ref69/cit69
ref12/cit12
ref15/cit15
ref62/cit62
ref66/cit66
ref41/cit41
ref58/cit58
ref22/cit22
ref33/cit33
ref30/cit30
ref47/cit47
ref1/cit1
Gualerzi C. O. (ref4/cit4) 2014
ref44/cit44
ref70/cit70
ref7/cit7
Hobbie, SN (WOS:000250683600018) 2007; 35
Carter, AP (WOS:000089390700037) 2000; 407
CRICH, D (WOS:A1988R183500013) 1988
Vandebona, H (WOS:000263028800028) 2009; 360
ANELLI, PL (WOS:A1987H814800038) 1987; 52
Akbergenov, R (WOS:000299455400020) 2011
Huth, ME (WOS:000348962700017) 2015; 125
Aggen, JB (WOS:000284155000017) 2010; 54
DESS, DB (WOS:A1983RP44600070) 1983; 48
Duggal, P (WOS:000210278000001) 2007; 7
Armstrong, ES (WOS:000303216800007) 2012
Wang, J. (000413503300040.73) 2007
Wright, PM (WOS:000340526400003) 2014; 53
Kato, T (WOS:000368464200004) 2015; 1
Chen, W (WOS:000340353500019) 2014; 5
Bacot-Davis, VR (WOS:000370707500008) 2016; 7
François, B (WOS:000232593700040) 2005; 33
FUJISAWA, K (WOS:A1974U169200005) 1974; 27
Mandhapati, AR (WOS:000341623300017) 2014; 9
Haddad, Jalal (BCI:BCI200300101283) 2001
Jiang, L (WOS:000071241100005) 1998; 39
Houghton, JL (WOS:000277725000003) 2010; 11
Perez-Fernandez, D (WOS:000331084400021) 2014; 5
Blount, KF (WOS:000230434200037) 2005; 127
Huth, M. E. (000413503300040.44) 2011
Kaul, M (WOS:000181698300007) 2003; 326
BEAUCLERK, AAD (WOS:A1987G208300008) 1987; 193
Noeske, J (WOS:000352317000013) 2015; 22
Garneau-Tsodikova, S (WOS:000370707500002) 2016; 7
Doi, Y (WOS:000247029700017) 2007; 45
OCONNOR, S (WOS:A1976BT92100003) 1976; 41
Chen, L (WOS:000259568500022) 2008; 16
Francis, SP (WOS:000314887200031) 2013; 33
MOOTOO, DR (WOS:A1986E719400008) 1986
Zhanel, GG (WOS:000303630700013) 2012; 10
Kato, T (WOS:000407665100003) 2017; 448
O'Shea, R (WOS:000255906300001) 2008; 51
Livermore, DM (WOS:000285417700005) 2011; 66
Becker, B (WOS:000314008000011) 2013; 8
Holdren, J. P. (000413503300040.41) 2014
Bastida, A (WOS:000234547700046) 2006; 128
Matsushita, T (WOS:000357062000037) 2015; 137
OKADA, K (WOS:A1988R625200047) 1988; 110
Talaska, A. E. (000413503300040.70) 2007
Peloquin, CA (WOS:000221477400005) 2004; 38
Meyer, M (WOS:000344158600072) 2014; 58
Hobbie, SN (WOS:000262092800058) 2008; 105
Matt, T (WOS:000306641100056) 2012; 109
Böttger, EC (WOS:000323094400002) 2013; 303
MOOTOO, DR (WOS:A1987K340800029) 1987
BARTON, DHR (WOS:A1983RF66000012) 1983
Chu, LL (WOS:000340079800017) 2014; 136
Hobbie, SN (WOS:000253846500015) 2008; 105
Avent, ML (WOS:000292103400002) 2011; 41
PREZANT, TR (WOS:A1993LJ84200018) 1993; 4
Kondo, J. (000413503300040.50) 2014
(000413503300040.1) 1982
Pathak, R (WOS:000233767500017) 2005; 88
Bitner-Glindzicz, M (WOS:000263028800027) 2009; 360
KECK, GE (WOS:A1984RY83500008) 1984; 25
Maianti, JP (WOS:000370707500017) 2016; 7
Hanessian, S (WOS:000344376400010) 2014; 5
DeMico, A (WOS:A1997XZ71900043) 1997; 62
Gualerzi, C. O. (000413503300040.34) 2014
ASAKO, T (WOS:A1978GN32100022) 1978; 11
Herzog, IM (WOS:000383111300021) 2016; 59
Galimand, M (WOS:000184449800027) 2003; 47
Fischbach, MA (WOS:000269382300030) 2009; 325
BOCK, K (WOS:A1994NL93200001) 1994; 13
Pathak, R (WOS:000259049900016) 2008; 91
Mingeot-Leclercq, MP (WOS:000080035100002) 1999; 43
Pfister, P (WOS:000185870900018) 2003; 4
(000413503300040.2) 2013
Wachino, J (WOS:000307417100001) 2012; 15
Duscha, S (WOS:000345459000061) 2014; 5
References_xml – ident: ref7/cit7
  doi: 10.1002/cbic.200900779
– ident: ref46/cit46
  doi: 10.1021/ja0543144
– ident: ref76/cit76
  doi: 10.1016/j.drup.2012.05.001
– ident: ref13/cit13
  doi: 10.1128/AAC.00572-10
– ident: ref60/cit60
  doi: 10.1016/S0040-4039(97)10599-8
– ident: ref15/cit15
  doi: 10.1039/C5MD00429B
– ident: ref68/cit68
  doi: 10.1073/pnas.0707265105
– ident: ref10/cit10
  doi: 10.1021/jm700967e
– ident: ref33/cit33
  doi: 10.1021/acs.jmedchem.6b00793
– ident: ref50/cit50
  doi: 10.1002/cmdc.201402146
– ident: ref36/cit36
  doi: 10.1523/JNEUROSCI.3430-12.2013
– ident: ref27/cit27
  doi: 10.1038/ng0793-289
– ident: ref38/cit38
  doi: 10.1073/pnas.1204073109
– ident: ref39/cit39
  doi: 10.1128/AAC.03239-14
– ident: ref35/cit35
  doi: 10.1007/978-3-7091-0215-2_20
– ident: ref53/cit53
  doi: 10.1021/jo971046m
– ident: ref26/cit26
  doi: 10.1172/JCI77424
– ident: ref72/cit72
  doi: 10.1039/C5MD00384A
– ident: ref64/cit64
  doi: 10.1021/ja00234a047
– ident: ref12/cit12
– ident: ref45/cit45
  doi: 10.1021/ja050918w
– ident: ref29/cit29
  doi: 10.1056/NEJMc0806397
– ident: ref37/cit37
  doi: 10.1093/nar/gkm658
– ident: ref55/cit55
  doi: 10.1039/C39860001570
– ident: ref11/cit11
  doi: 10.1201/9780585407500.ch11
– ident: ref61/cit61
  doi: 10.1021/jo00388a038
– ident: ref14/cit14
  doi: 10.1586/eri.12.25
– ident: ref19/cit19
  doi: 10.1016/j.bmc.2008.08.053
– ident: ref71/cit71
  doi: 10.1021/acsinfecdis.5b00069
– ident: ref43/cit43
  doi: 10.1021/jacs.5b02248
– ident: ref6/cit6
  doi: 10.1039/C5MD00344J
– ident: ref48/cit48
  doi: 10.1039/C4SC01626B
– ident: ref52/cit52
  doi: 10.1002/hlca.200890167
– ident: ref18/cit18
  doi: 10.7164/antibiotics.27.677
– volume-title: Antibiotics: Targets, Mechanisms and Resistance
  year: 2014
  ident: ref4/cit4
– ident: ref75/cit75
  doi: 10.1128/AAC.47.8.2565-2571.2003
– ident: ref2/cit2
– ident: ref62/cit62
  doi: 10.1039/c39830000939
– ident: ref73/cit73
  doi: 10.1016/0022-2836(87)90349-4
– ident: ref30/cit30
  doi: 10.1038/35030019
– ident: ref54/cit54
  doi: 10.1016/S0040-4039(00)99857-5
– ident: ref5/cit5
  doi: 10.1002/anie.201310843
– ident: ref59/cit59
– ident: ref32/cit32
– ident: ref63/cit63
  doi: 10.1039/C39880001461
– ident: ref69/cit69
  doi: 10.1016/S0022-2836(02)01452-3
– ident: ref16/cit16
  doi: 10.1002/9780470149676.ch9
– ident: ref31/cit31
  doi: 10.1038/nsmb.2994
– ident: ref9/cit9
  doi: 10.1007/978-1-4614-1400-1_7
– ident: ref23/cit23
  doi: 10.1186/1472-6815-7-5
– ident: ref24/cit24
  doi: 10.1086/420742
– ident: ref8/cit8
  doi: 10.1021/cb3005116
– ident: ref70/cit70
  doi: 10.1002/cbic.200300657
– ident: ref65/cit65
  doi: 10.1021/ja505964r
– ident: ref1/cit1
– ident: ref56/cit56
  doi: 10.1039/C39870001462
– ident: ref66/cit66
  doi: 10.1016/j.carres.2017.05.015
– ident: ref34/cit34
  doi: 10.1073/pnas.0811258106
– ident: ref47/cit47
  doi: 10.1093/nar/gki862
– ident: ref25/cit25
  doi: 10.1155/2011/937861
– ident: ref41/cit41
  doi: 10.1038/ncomms4112
– ident: ref42/cit42
  doi: 10.1128/mBio.01827-14
– ident: ref3/cit3
  doi: 10.1126/science.1176667
– volume: 43
  start-page: 1003
  year: 1999
  ident: ref21/cit21
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.43.5.1003
– ident: ref74/cit74
  doi: 10.1086/518605
– ident: ref51/cit51
  doi: 10.1002/hlca.200590240
– ident: ref20/cit20
  doi: 10.1039/C4MD00119B
– ident: ref49/cit49
  doi: 10.1080/07328309408011662
– ident: ref57/cit57
  doi: 10.1021/jo00170a070
– ident: ref28/cit28
  doi: 10.1056/NEJMc0806396
– ident: ref77/cit77
  doi: 10.1093/jac/dkq408
– ident: ref22/cit22
  doi: 10.1111/j.1445-5994.2011.02452.x
– ident: ref44/cit44
  doi: 10.3987/S(N)-1978-01-0197
– ident: ref17/cit17
  doi: 10.1016/j.heares.2013.01.006
– ident: ref58/cit58
  doi: 10.1021/jo00874a003
– volume: 88
  start-page: 2967
  year: 2005
  ident: WOS:000233767500017
  article-title: Design and synthesis of aminoglycoside antibiotics to selectively target 16S ribosomal RNA position 1408
  publication-title: HELVETICA CHIMICA ACTA
– volume: 193
  start-page: 661
  year: 1987
  ident: WOS:A1987G208300008
  article-title: SITES OF ACTION OF 2 RIBOSOMAL-RNA METHYLASES RESPONSIBLE FOR RESISTANCE TO AMINOGLYCOSIDES
  publication-title: JOURNAL OF MOLECULAR BIOLOGY
– volume: 13
  start-page: 513
  year: 1994
  ident: WOS:A1994NL93200001
  article-title: A CONFORMATIONAL STUDY OF HYDROXYMETHYL GROUPS IN CARBOHYDRATES INVESTIGATED BY H-1-NMR SPECTROSCOPY
  publication-title: JOURNAL OF CARBOHYDRATE CHEMISTRY
– volume: 35
  start-page: 6086
  year: 2007
  ident: WOS:000250683600018
  article-title: Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria
  publication-title: NUCLEIC ACIDS RESEARCH
  doi: 10.1093/nar/gkm658
– volume: 58
  start-page: 6938
  year: 2014
  ident: WOS:000344158600072
  article-title: In Vivo Efficacy of Apramycin in Murine Infection Models
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.03239-14
– volume: 105
  start-page: 20888
  year: 2008
  ident: WOS:000262092800058
  article-title: Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.0811258106
– volume: 41
  start-page: 2087
  year: 1976
  ident: WOS:A1976BT92100003
  article-title: APRAMYCIN, A UNIQUE AMINOCYCLITOL ANTIBIOTIC
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
– volume: 38
  start-page: 1538
  year: 2004
  ident: WOS:000221477400005
  article-title: Aminoglycoside toxicity: Daily versus thrice-weekly dosing for treatment of mycobacterial diseases
  publication-title: CLINICAL INFECTIOUS DISEASES
– volume: 41
  start-page: 441
  year: 2011
  ident: WOS:000292103400002
  article-title: Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity
  publication-title: INTERNAL MEDICINE JOURNAL
  doi: 10.1111/j.1445-5994.2011.02452.x
– volume: 11
  start-page: 880
  year: 2010
  ident: WOS:000277725000003
  article-title: The Future of Aminoglycosides: The End or Renaissance?
  publication-title: CHEMBIOCHEM
  doi: 10.1002/cbic.200900779
– volume: 11
  start-page: 197
  year: 1978
  ident: WOS:A1978GN32100022
  article-title: CHEMICAL TRANSFORMATION OF 3'-CHLORO-3'-DEOXYAMINOGLYCOSIDES INTO NEW CYCLIC PSEUDO-TRISACCHARIDES
  publication-title: HETEROCYCLES
– volume: 33
  start-page: 5677
  year: 2005
  ident: WOS:000232593700040
  article-title: Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding
  publication-title: NUCLEIC ACIDS RESEARCH
  doi: 10.1093/nar/gki862
– volume: 10
  start-page: 459
  year: 2012
  ident: WOS:000303630700013
  article-title: Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
  publication-title: EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
  doi: 10.1586/ERI.12.25
– volume: 45
  start-page: 88
  year: 2007
  ident: WOS:000247029700017
  article-title: 16S ribosomal RNA methylation: Emerging resistance mechanism against aminoglycosides
  publication-title: CLINICAL INFECTIOUS DISEASES
  doi: 10.1086/518605
– volume: 43
  start-page: 1003
  year: 1999
  ident: WOS:000080035100002
  article-title: Aminoglycosides: Nephrotoxicity
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
– volume: 91
  start-page: 1533
  year: 2008
  ident: WOS:000259049900016
  article-title: Synthesis and evaluation of paromomycin derivatives modified at C(4′)
  publication-title: HELVETICA CHIMICA ACTA
– volume: 33
  start-page: 3079
  year: 2013
  ident: WOS:000314887200031
  article-title: A Novel Role of Cytosolic Protein Synthesis Inhibition in Aminoglycoside Ototoxicity
  publication-title: JOURNAL OF NEUROSCIENCE
  doi: 10.1523/JNEUROSCI.3430-12.2013
– volume: 25
  start-page: 265
  year: 1984
  ident: WOS:A1984RY83500008
  article-title: STEREOCONTROLLED ADDITIONS OF ALLYLTRI-NORMAL-BUTYL-STANNANE TO ALPHA-HYDROXYALDEHYDE DERIVATIVES - A USEFUL ROUTE TO MONOPROTECTED ERYTHRO OR THREO DIOLS
  publication-title: TETRAHEDRON LETTERS
– volume: 7
  start-page: ARTN 5
  year: 2007
  ident: WOS:000210278000001
  article-title: Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up
  publication-title: BMC EAR NOSE AND THROAT DISORDERS
  doi: 10.1186/1472-6815-7-5
– volume: 4
  start-page: 289
  year: 1993
  ident: WOS:A1993LJ84200018
  article-title: MITOCHONDRIAL RIBOSOMAL-RNA MUTATION ASSOCIATED WITH BOTH ANTIBIOTIC-INDUCED AND NON-SYNDROMIC DEAFNESS
  publication-title: NATURE GENETICS
– volume: 137
  start-page: 7706
  year: 2015
  ident: WOS:000357062000037
  article-title: Influence of 4′-O-Glycoside Constitution and Configuration on Ribosomal Selectivity of Paromomycin
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/jacs.5b02248
– year: 2011
  ident: 000413503300040.44
  publication-title: Int. J. Otolaryngol
– start-page: 249
  year: 2011
  ident: WOS:000299455400020
  article-title: Decoding and deafness: Two sides of a coin
  publication-title: RIBOSOMES: STRUCTURE, FUNCTION, AND DYNAMICS
– volume: 326
  start-page: 1373
  year: 2003
  ident: WOS:000181698300007
  article-title: Coupling of drug protonation to the specific binding of aminoglycosides to the A site of 16 S rRNA: Elucidation of the number of drug amino groups involved and their identities
  publication-title: JOURNAL OF MOLECULAR BIOLOGY
  doi: 10.1016/S0022-2836(02)01452-3
– start-page: 229
  year: 2012
  ident: WOS:000303216800007
  article-title: Aminoglycosides
  publication-title: ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2
  doi: 10.1007/978-1-4614-1400-1_7
– volume: 39
  start-page: 355
  year: 1998
  ident: WOS:000071241100005
  article-title: Borane/Bu2BOTf:: A mild reagent for the regioselective reductive ring opening of benzylidene acetals in carbohydrates
  publication-title: TETRAHEDRON LETTERS
– volume: 5
  start-page: ARTN e01827-14
  year: 2014
  ident: WOS:000345459000061
  article-title: Identification and Evaluation of Improved 4′-O-(Alkyl) 4,5-Disubstituted 2-Deoxystreptamines as Next-Generation Aminoglycoside Antibiotics
  publication-title: MBIO
  doi: 10.1128/mBio.01827-14
– start-page: 1462
  year: 1987
  ident: WOS:A1987K340800029
  article-title: AN OXIDATIVE REDUCTIVE, NON-HYDROLYTIC PROCEDURE FOR UNRAVELING COMPLEX ACETALS (GLYCOSIDES) - A POSSIBLE CHEMICAL ROLE FOR THE EXOANOMERIC EFFECT
  publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS
– volume: 127
  start-page: 9818
  year: 2005
  ident: WOS:000230434200037
  article-title: Conformational constraint as a means for understanding RNA-aminoglycoside specificity
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja050918w
– volume: 109
  start-page: 10984
  year: 2012
  ident: WOS:000306641100056
  article-title: Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.1204073109
– volume: 53
  start-page: 8840
  year: 2014
  ident: WOS:000340526400003
  article-title: The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
  publication-title: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
  doi: 10.1002/anie.201310843
– volume: 15
  start-page: 133
  year: 2012
  ident: WOS:000307417100001
  article-title: Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update
  publication-title: DRUG RESISTANCE UPDATES
  doi: 10.1016/j.drup.2012.05.001
– volume: 360
  start-page: 640
  year: 2009
  ident: WOS:000263028800027
  article-title: Prevalence of Mitochondrial 1555A>G Mutation in European Children
  publication-title: NEW ENGLAND JOURNAL OF MEDICINE
– start-page: 939
  year: 1983
  ident: WOS:A1983RF66000012
  article-title: NEW AND IMPROVED METHODS FOR THE RADICAL DECARBOXYLATION OF ACIDS
  publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS
– volume: 16
  start-page: 8940
  year: 2008
  ident: WOS:000259568500022
  article-title: Structure-toxicity relationship of aminoglycosides:: Correlation of 2′-amine basicity with acute toxicity in pseudo-disaccharide scaffolds
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY
  doi: 10.1016/j.bmc.2008.08.053
– year: 2014
  ident: 000413503300040.34
  publication-title: Antibiotics: Targets, Mechanisms and Resistance
– start-page: 1
  year: 2014
  ident: 000413503300040.41
  publication-title: Report to the President on Combatting Antibiotic Resistance
– volume: 128
  start-page: 100
  year: 2006
  ident: WOS:000234547700046
  article-title: Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja0543144
– volume: 7
  start-page: 170
  year: 2016
  ident: WOS:000370707500017
  article-title: Structural hybridization of three aminoglycoside antibiotics yields a potent broad-spectrum bactericide that eludes bacterial resistance enzymes
  publication-title: MEDCHEMCOMM
  doi: 10.1039/c5md00429b
– start-page: 353
  year: 2001
  ident: BCI:BCI200300101283
  article-title: Methodologies in syntheses of aminoglycoside antibiotics.
  publication-title: Glycochemistry: Principles, synthesis, and applications
– volume: 136
  start-page: 10886
  year: 2014
  ident: WOS:000340079800017
  article-title: Carboxylic Acids as A Traceless Activation Group for Conjugate Additions: A Three-Step Synthesis of (±)-Pregabalin
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja505964r
– volume: 66
  start-page: 48
  year: 2011
  ident: WOS:000285417700005
  article-title: Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
  publication-title: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
  doi: 10.1093/jac/dkq408
– start-page: 453
  year: 2014
  ident: 000413503300040.50
  publication-title: Antibioitcs: Targets, Mechanisms and Resistance
– volume: 5
  start-page: 4621
  year: 2014
  ident: WOS:000344376400010
  article-title: Synthesis, broad spectrum antibacterial activity, and X-ray co-crystal structure of the decoding bacterial ribosomal A-site with 4′-deoxy-4′-fluoro neomycin analogs
  publication-title: CHEMICAL SCIENCE
  doi: 10.1039/c4sc01626b
– volume: 325
  start-page: 1089
  year: 2009
  ident: WOS:000269382300030
  article-title: Antibiotics for Emerging Pathogens
  publication-title: SCIENCE
  doi: 10.1126/science.1176667
– volume: 47
  start-page: 2565
  year: 2003
  ident: WOS:000184449800027
  article-title: Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.47.8.2565-2571.2003
– volume: 407
  start-page: 340
  year: 2000
  ident: WOS:000089390700037
  article-title: Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics
  publication-title: NATURE
– volume: 54
  start-page: 4636
  year: 2010
  ident: WOS:000284155000017
  article-title: Synthesis and Spectrum of the Neoglycoside ACHN-490
  publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
  doi: 10.1128/AAC.00572-10
– start-page: 1570
  year: 1986
  ident: WOS:A1986E719400008
  article-title: REMOTE PARTICIPATION IN ELECTROPHILIC REACTIONS OF PROTECTED POLYOLS
  publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS
– start-page: 255
  year: 2007
  ident: 000413503300040.70
  publication-title: Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery
– volume: 59
  start-page: 8008
  year: 2016
  ident: WOS:000383111300021
  article-title: Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/acs.jmedchem.6b00793
– volume: 105
  start-page: 3244
  year: 2008
  ident: WOS:000253846500015
  article-title: Mitochondrial deafness alleles confer misreading of the genetic code
  publication-title: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
  doi: 10.1073/pnas.0707265105
– volume: 22
  start-page: 336
  year: 2015
  ident: WOS:000352317000013
  article-title: High-resolution structure of the Escherichia coli ribosome
  publication-title: NATURE STRUCTURAL & MOLECULAR BIOLOGY
  doi: 10.1038/nsmb.2994
– volume: 52
  start-page: 2559
  year: 1987
  ident: WOS:A1987H814800038
  article-title: FAST AND SELECTIVE OXIDATION OF PRIMARY ALCOHOLS TO ALDEHYDES OR TO CARBOXYLIC-ACIDS AND OF SECONDARY ALCOHOLS TO KETONES MEDIATED BY OXOAMMONIUM SALTS UNDER 2-PHASE CONDITIONS
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
– volume: 8
  start-page: 105
  year: 2013
  ident: WOS:000314008000011
  article-title: Aminoglycoside Antibiotics in the 21st Century
  publication-title: ACS CHEMICAL BIOLOGY
  doi: 10.1021/cb3005116
– volume: 303
  start-page: 12
  year: 2013
  ident: WOS:000323094400002
  article-title: The mitochondrion: A perpetrator of acquired hearing loss
  publication-title: HEARING RESEARCH
  doi: 10.1016/j.heares.2013.01.006
– volume: 9
  start-page: 2074
  year: 2014
  ident: WOS:000341623300017
  article-title: Importance of the 6′-Hydroxy Group and Its Configuration for Apramycin Activity
  publication-title: CHEMMEDCHEM
  doi: 10.1002/cmdc.201402146
– start-page: 1461
  year: 1988
  ident: WOS:A1988R183500013
  article-title: STEREOSELECTIVE FREE-RADICAL REACTIONS IN THE PREPARATION OF 2-DEOXY-BETA-D-GLUCOSIDES
  publication-title: JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS
– volume: 7
  start-page: 103
  year: 2016
  ident: WOS:000370707500008
  article-title: Drug-target networks in aminoglycoside resistance: hierarchy of priority in structural drug design
  publication-title: MEDCHEMCOMM
  doi: 10.1039/c5md00384a
– volume: 62
  start-page: 6974
  year: 1997
  ident: WOS:A1997XZ71900043
  article-title: A versatile and highly selective hypervalent iodine (III)/2,2,6,6-tetramethyl-1-piperidinyloxyl-mediated oxidation of alcohols to carbonyl compounds
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
– volume: 4
  start-page: 1078
  year: 2003
  ident: WOS:000185870900018
  article-title: The molecular basis for A-site mutations conferring aminoglycoside resistance:: Relationship between ribosomal susceptibility and X-ray crystal structures
  publication-title: CHEMBIOCHEM
  doi: 10.1002/cbic.200300657
– volume: 448
  start-page: 10
  year: 2017
  ident: WOS:000407665100003
  article-title: Stereospecific synthesis of methyl 2-amino-2-deoxy-(6S)-deuterio-α,β-D-glucopyranoside and methyl 2,6-diamino-2,6-dideoxy-(6R)deuterio-α,β-D-glucopyranoside: Side chain conformations of the 2amino-2-deoxy and 2,6-diamino-2,6-dideoxyglucopyranosides
  publication-title: CARBOHYDRATE RESEARCH
  doi: 10.1016/j.carres.2017.05.015
– volume: 125
  start-page: 583
  year: 2015
  ident: WOS:000348962700017
  article-title: Designer aminoglycosides prevent cochlear hair cell loss and hearing loss
  publication-title: JOURNAL OF CLINICAL INVESTIGATION
  doi: 10.1172/JCI77424
– volume: 360
  start-page: 642
  year: 2009
  ident: WOS:000263028800028
  article-title: Prevalence of Mitochondrial 1555A>G Mutation in Adults of European Descent
  publication-title: NEW ENGLAND JOURNAL OF MEDICINE
– volume: 1
  start-page: 479
  year: 2015
  ident: WOS:000368464200004
  article-title: Synthesis and Antiribosomal Activities of 4′-Ο-, 6′-Ο-, 4"-Ο-, 4′,6′-Ο and 4",6"-Ο-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5-and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside Antibiotics
  publication-title: ACS INFECTIOUS DISEASES
  doi: 10.1021/acsinfecdis.5b00069
– volume: 5
  start-page: ARTN 3112
  year: 2014
  ident: WOS:000331084400021
  article-title: 4′-O-substitutions determine selectivity of aminoglycoside antibiotics
  publication-title: NATURE COMMUNICATIONS
  doi: 10.1038/ncomms4112
– volume: 27
  start-page: 677
  year: 1974
  ident: WOS:A1974U169200005
  article-title: AMINOGLYCOSIDE ANTIBIOTICS .7. ACUTE TOXICITY OF AMINOGLYCOSIDE ANTIBIOTICS
  publication-title: JOURNAL OF ANTIBIOTICS
– start-page: 141
  year: 2007
  ident: 000413503300040.73
  publication-title: Aminoglycoside Antibiotics
– volume: 48
  start-page: 4155
  year: 1983
  ident: WOS:A1983RP44600070
  article-title: READILY ACCESSIBLE 12-I-5 OXIDANT FOR THE CONVERSION OF PRIMARY AND SECONDARY ALCOHOLS TO ALDEHYDES AND KETONES
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
– start-page: 1
  year: 2013
  ident: 000413503300040.2
  publication-title: Antibiotic Resistance Threats in the United States, 2013
– volume: 110
  start-page: 8736
  year: 1988
  ident: WOS:A1988R625200047
  article-title: A NEW AND PRACTICAL METHOD OF DECARBOXYLATION - PHOTOSENSITIZED DECARBOXYLATION OF N-ACYLOXYPHTHALIMIDES VIA ELECTRON-TRANSFER MECHANISM
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
– volume: 51
  start-page: 2871
  year: 2008
  ident: WOS:000255906300001
  article-title: Physicochemical properties of antibacterial compounds: Implications for drug discovery
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm700967e
– year: 1982
  ident: 000413503300040.1
  publication-title: US Patent
– volume: 5
  start-page: 1179
  year: 2014
  ident: WOS:000340353500019
  article-title: Synthesis, antiribosomal and antibacterial activity of 4′-O-glycopyranosyl paromomycin aminoglycoside antibiotics
  publication-title: MEDCHEMCOMM
  doi: 10.1039/c4md00119b
– volume: 7
  start-page: 11
  year: 2016
  ident: WOS:000370707500002
  article-title: Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
  publication-title: MEDCHEMCOMM
  doi: 10.1039/c5md00344j
SSID ssj0004281
Score 2.4143677
Snippet The preparation of a series of four analogues of the aminoglycoside antibiotics neomycin and paromomycin is described in which ring I, involved in critical...
Source Web of Science
SourceID pubmedcentral
proquest
pubmed
webofscience
crossref
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 14611
SubjectTerms Anti-Bacterial Agents - chemical synthesis
Anti-Bacterial Agents - chemistry
antibacterial properties
Chemistry
Chemistry, Multidisciplinary
diastereomers
Gram-positive bacteria
moieties
Nebramycin - analogs & derivatives
Nebramycin - chemical synthesis
Nebramycin - chemistry
neomycin
Neomycin - analogs & derivatives
Paromomycin - analogs & derivatives
Paromomycin - chemical synthesis
pathogens
Physical Sciences
ribosomes
Ribosomes - metabolism
Science & Technology
therapeutics
translation (genetics)
Title Structure-Based Design and Synthesis of Apramycin–Paromomycin Analogues: Importance of the Configuration at the 6′-Position and Differences between the 6′-Amino and Hydroxy Series
URI http://dx.doi.org/10.1021/jacs.7b07754
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000413503300040
https://www.ncbi.nlm.nih.gov/pubmed/28892368
https://www.proquest.com/docview/1938188307
https://www.proquest.com/docview/2116902652
https://pubmed.ncbi.nlm.nih.gov/PMC5647259
Volume 139
WOS 000413503300040
WOSCitedRecordID wos000413503300040
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVABC
  databaseName: American Chemical Society Journals
  customDbUrl:
  eissn: 1520-5126
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004281
  issn: 0002-7863
  databaseCode: ACS
  dateStart: 18790101
  isFulltext: true
  titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals
  providerName: American Chemical Society
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbhMxELagHODC_89SQK5UTmij2Nkfm1tIKQEJVClU6i3yru2yarOpuptDOPUdeBNufZ0-CTNeb0JSInpLNmNtPB57vrHH3xCyG-mIW9FToYZgIIyU1KFSKg7jlFmYW5kSBjf0v35LhofRl6P4aJkgu36Cz5EfKK86aeao2m6TOzwRDIOs_mC0vP_IBWthbiqSnk9wX2-NDiivVh3QNVT57-TINYfknM_-A_KpvcLT5JycdGZ11sl_Xmd0_E-_HpL7Hn_SfmMwj8gtUz4mdwdt2bcn5HLkGGVn5yb8AB5O0z2X40FVqeloXgJerIqKTi3tn52ryTwvyquLXwcKs_rcN4o0J7gfVL2nnycO3UOHsAE0pXjBsDieNWZHVe0eJlcXv8MDnz3mXrTny7bAIkZ9JtlSsj8pyqkTG841aoTiFp-pnpLD_Y_fB8PQ13cIVcR4HQobwVJsTZYZkSeWcZNaARBEwAgzrXmkTQ7RjMUY1morYyOVlFlXZyaKpGa9Z2SrnJbmBaEWSWcA-lkMqKSRqNZEWFhCY2u7VgRkB9Q99vOzGrujdw6hDz71gxCQd61hjHNPkI51Ok43SL9dSJ81xCAb5HZaGxvDSOJxjCrNdAb_QSJaErDIbpaB8DyRECbHPCDPG7tcvI0LAeg8gb6lKxa7EEDm8NVfyuKHYxCPsWhALAOy-7dtLxrilGI9PODGT92AsJuIDbzOkEyhfnkDhW-TexxBEuYHiVdkC8zbvAaIV2dv3Pz-AyknUXA
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbhMxEB5BOZQL_5Tl15XKCW2V3eyPzS2kVCm0UaW0Um-Rd23DCrKpuptDOPUdeBNuvE6fhBnH2ZBApNwSZ5y1Z8eeb-zxZ4C9SEWh4W3pKwwG_EgK5UspYz9OA4NjK5Nc04L-ST_pnUefLuILd1idzsJgIyr8p8pu4i_YBYgmCAvTzDK23YY7lgSFkFB3sDgGGfJgjnZTnrRdnvtqbfJDebXsh_4Bl__PkVzxS9YHHd6HftN6m3rybX9SZ_v5jxVix4279wDuOTTKOjPzeQi3dPkItrvzS-Aew--B5ZedXGn_A_o7xQ5sxgeTpWKDaYnosSoqNjasc3klR9O8KG-uf55KyvGz3xiRntDqUPWeHY0s1sd-UQWsyui4YfFlMjNCJmtbmNxc__JPXS6ZfdCBu8QFpzTm8soWkp1RUY6tWG-qSDGMFvx09QTODz-edXu-u-3Bl1EQ1j43EU7MRmeZ5nliglCnhiMg4TxIA6XCSOkcYxtDEa1RRsRaSCGylsp0FAkVtJ_CVjku9TNghihoEAgaCq-EFqTWhBucUGNjWoZ7sIvqHrrRWg3tRnyIgRCVupfgwbu5fQxzR5dOt3Z8XyP9tpG-nNGErJHbnZvaEN8kbc7IUo8n2AZB2InjlLteBoP1RGDQHIce7MzMs3layDli9QT7li4ZbiNAPOLLv5TFV8snHtMVArHwYO9vE28q0sgK2rTdTZ9aHgSbiHWdzohaoX6-gcLfwHbv7OR4eHzU__wC7oYEnyhziL-ELTR1_QrBX529tkP-D-5NWds
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbGkGAv3DfC1ZPGE8pUp7nYvJWWquMyVZRJe4uc2IYImlZL-lCe9h_4J7zxd_ZLOMd1M1qoNN5yOU5i5xz7O_bxdwg5CFUYGN6WvgJnwA-lUL6UMvKjhBmwrUxyjRP6H47jwUn49jQ63SJsuRcGPqKCJ1V2ER-teqqMYxhAqiC4kWSWte0auR4h-xuioe7ocitkwNkS8SY8brtY9_XSOBbl1epY9BfA_Hec5NrYZMeh_m3ysamBDT_5ejirs8P8-xq5439V8Q655VAp7SzU6C7Z0uU9crO7TAZ3n_waWZ7Z2Zn2X8O4p2jPRn5QWSo6mpeAIquiohNDO9MzOZ7nRXlx_mMoMdbPnlEkP8FZouoVPRpbzA91wwJQlOK2w-LzbKGMVNb2Ynxx_tMfupgy-6KeS-YCXRt18WWXkp1xUU6s2GCusHEoTvzp6gE56b_51B34LuuDL0MW1D43IXTQRmeZ5nlsWKATwwGYcM4SplQQKp2Dj2PQszXKiEgLKUTWUpkOQ6FYe5dsl5NSPyTUIBUNAEKDbpbQAps15gY61siYluEe2YfmTp3VVqldkA_AIcKr7id45OVSR9Lc0aZj9o5vG6RfNNLTBV3IBrn9pbql8CdxkUaWejKDbxCIoTh0vZtlwGmPBTjPUeCRvYWKNm8LOAfMHkPdkhXlbQSQT3z1Tll8sbziEaYSiIRHDv5U86YgWhdr47I3HrU8wq4i1nVthhQL9aMrNPhzcmPY66fvj47fPSY7AaIoDCDiT8g2aLp-Chiwzp5Zq_8NkU5cVQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure-Based+Design+and+Synthesis+of+Apramycin-Paromomycin+Analogues%3A+Importance+of+the+Configuration+at+the+6%E2%80%B2-Position+and+Differences+between+the+6%E2%80%B2-Amino+and+Hydroxy+Series&rft.jtitle=Journal+of+the+American+Chemical+Society&rft.au=Mandhapati%2C+Appi+Reddy&rft.au=Yang%2C+Guanyu&rft.au=Kato%2C+Takayuki&rft.au=Shcherbakov%2C+Dimitri&rft.date=2017-10-18&rft.pub=Amer+Chemical+Soc&rft.issn=0002-7863&rft.volume=139&rft.issue=41&rft.spage=14611&rft.epage=14619&rft_id=info:doi/10.1021%2Fjacs.7b07754&rft_id=info%3Apmid%2F28892368&rft.externalDBID=n%2Fa&rft.externalDocID=000413503300040
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-7863&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-7863&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-7863&client=summon